Barclays Capital Reaffirms Overweight Rating on Bed Bath & Beyond (BBBY)
Shares of Bed Bath & Beyond opened at 69.16 on Thursday. Bed Bath & Beyond has a one year low of $48.75 and a one year high of $72.75. The company has a market cap of $15.982 billion and a P/E ratio of 17.03.
Bed Bath & Beyond last issued its quarterly earnings data on Wednesday, April 4th. The company reported $1.48 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.33 by $0.15. The company’s revenue for the quarter was up 9.1% on a year-over-year basis. On average, analysts predict that Bed Bath & Beyond will post $1.08 earnings per share next quarter.
A number of other analysts have also recently weighed in on BBBY. Analysts at Oppenheimer (NYSE: OPY) reiterated an “outperform” rating on shares of Bed Bath & Beyond in a research note to investors on Friday, May 11st. They now have a $84.00 price target on the stock. Separately, analysts at Credit Suisse (NYSE: CS) upgraded shares of Bed Bath & Beyond from a “neutral” rating to an “outperform” rating in a research note to investors on Friday, May 11st. They now have a $75.00 price target on the stock, down previously from $91.00. Finally, analysts at Wells Fargo & Co. (NYSE: WFC) reiterated a “market perform” rating on shares of Bed Bath & Beyond in a research note to investors on Thursday, May 3rd.
Bed Bath & Beyond Inc., along with its subsidiaries, is a chain of retail stores, operating under the names Bed Bath & Beyond (BBB), Christmas Tree Shops (CTS), Harmon and Harmon Face Values (Harmon) and buybuy BABY.